Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to bone marrow biopsies. Quest Diagnostics has announced the launch of a novel ...
As monoclonal antibody (mAb) development continues to evolve, new challenges are arising in the purification process, especially during the polishing stage. Innovations in flow-through technology – ...
SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ --Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel blood test that uses advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results